receptos

BioPharma

Arch Venture Partners plans to fund “wild-ass ideas” with new, $400 million venture fund

Tech venture behemoth Arch Venture Partners has announced its eighth venture fund just closed with more than $400 million in subscriptions and, as co-founder and managing director Robert Nelson just told Forbes, it’s looking to fund┬ácompanies with “contrarian philosophies.” Alex Konrad over at Forbes writes: That money will go to funding companies that cofounder and […]